11.12.2015 • NewsDede Willamspatent litigationRoche

Roche Wins Patent Dispute Against Cipla

An Indian court has unexpectedly sided with Swiss drugmaker Roche in a long-running patent dispute with Indian generics giant Cipla.

A two-judge panel for the Delhi High Court concluded that Cipla violated a patent for Roche’s lung cancer drug Tarceva (erlotinib) and ordered it to pay damages and the Swiss company’s legal fees.

The cost to Cipla will be determined at a later date, based to a large degree on the profits made from sales of its generic cancer drug Erlocip, for which the patent was violated.

Commentators said the decision flies in the face of multiple court decisions dating back to 2008 in the long-running case, all of which Cipla had won.

In the Roche decision, the panel said lower court rulings and a division assessment had erred in supporting Cipla’s challenge to the patent over a perceived lack of innovation and questions as to whether patent protection extends to different molecular configurations of the same ingredients.

At the same time, the judges declined to grant Roche an injunction to stop Cipla from marketing Erlocip, noting that the Indian patent is due to expire in March 2016.

Cipla has been accused of violating foreign drugmakers’ patents in India numerous times. In other 2015 cases, the company is reported to have won a patent challenge against Boehringer Ingelheim in March. Before that, it was successfully parried by an injunction filed by Novartis in January.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.